<DOC>
	<DOCNO>NCT00419965</DOCNO>
	<brief_summary>The primary objective study determine utility GRK2 differentiate normal patient patient group differ presence/absence HF symptom , systolic diastolic leave ventricular dysfunction , risk factor ; evaluate new assay provide similar value traditional method measure GRK2 level .</brief_summary>
	<brief_title>Measuring G Protein-coupled Receptor Kinase-2 ( GRK2 ) Blood Diagnose Treat Patients With Heart Failure</brief_title>
	<detailed_description>This study seek define beta-adrenergic receptor kinase molecule blood role improve biomarker use diagnosis , assessment management patient heart failure . We test blood cell sample level molecule , call `` G protein-coupled receptor kinase-2 '' ( GRK2 ) use exist method GRK2 quantification Koch laboratory use prototype enzyme immunoassay ( EIA ) method develop Johnson &amp; Johnson , Ortho-Clinical Diagnostics ( OCD ) .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Normal Controls : Individuals without HF , hypertension , diabetes , hyperlipidemia , coronary artery disease obesity ; Group I : Symptomatic Subjects Reduced LV Function , HF symptom , EF ≤ 40 % . Group II : Asymptomatic Patients LV dysfunction , HF symptom ( NYHA class I ATS score 0 1 , EF ≤ 40 % . Group III : Symptomatic Subjects Preserved LV Function , HF symptom , EF ≥ 50 % , diastolic dysfunction . Group IV : Asymptomatic High Risk Subjects Individuals normal heart function , HF symptom ( NYHA class I ATS score 0 1 ) , Preserved LV function ( EF ≥ 50 % ) , diastolic dysfunction . Also possess one cardiovascular high risk factor : diagnosis diabetes ; hyperlipidemia ; coronary artery disease ; renal insufficiency ; hypertension ; age &gt; 70 year Exclusion Criteria Pregnancy Not provide consent Inability provide consent Participation clinical study involve experimental therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>